Singleton Bill to Require Insurance Coverage for Biomarker Testing Advances in State Senate - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Health/Employee Benefits News
Newswires RSS Get our newsletter
Order Prints
December 15, 2024 Newswires
Share
Share
Post
Email

Singleton Bill to Require Insurance Coverage for Biomarker Testing Advances in State Senate

TAPinto Bordentown StaffTAPinto.net

TRENTON, NJ — Legislation that would require health insurers to cover biomarker testing has advanced in the New Jersey State Senate.

The bill, S-3098, unanimously passed the Senate Commerce Committee on Thursday by a 5-0 vote.

The measure, sponsored by Senators Troy Singleton (D-Burlington) and Vin Gopal (D-Monmouth), would ensure that state-regulated insurance plans cover biomarker testing for patients when it is supported by medical and scientific evidence, removing financial barriers to this innovation. Biomarkers are considered a vital tool in diagnosing and treating diseases including cancer.

"Despite evidence demonstrating the effectiveness of biomarker testing and targeted therapy, not all individuals currently benefit equitably from these advances," said Singleton, who represents Bordentown in the Legislature. "Dozens of states have made expanded biomarker testing part of their insurance laws, and this important proposal will ensure New Jersey is among them."

"When biomarker testing is not covered by insurance, patients are often forced to make an impossible choice: pay out-of-pocket costs that can reach thousands of dollars or forgo this critical testing altogether," said Senator Gopal (D-Monmouth). "Ensuring timely access to comprehensive biomarker testing supported by medical evidence will save lives, improve health outcomes, enhance quality of life, and reduce overall healthcare costs for New Jersey families."

Biomarker testing plays a pivotal role in advancing targeted cancer treatments, says Singleton and Gopal. By identifying specific cancer biomarkers - including proteins or genetic changes such as mutations, rearrangements, or fusions, the approach allows for therapies that directly target the specific cellular processes in cancer growth, spread, and progression.

Biomarker testing coverage has the potential to reduce disparities in healthcare treatments and outcomes by facilitating faster access to the treatments, which is likely to result in the best outcomes for all patients with coverage, the Senators continued. The testing can save lives, expedite treatment, avoid ineffective treatments, reduce adverse side effects, and potentially lower healthcare costs by matching patients with the treatments most likely to be effective, a practice known as precision medicine.

The bill stipulates that insurance coverage for biomarker testing would include any tests that have Federal Drug Administration or Centers for Medicare & Medicaid Services approval or those included in nationally recognized clinical practice guidelines. It does not require all biomarker tests to be covered.

To read the full text of the bill, CLICK HERE.

Older

This Bernie interview is how health insurance killing ways go unchallenged by the mainstream media.

Newer

Seven reasons health care costs more in America

Advisor News

  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
  • Semi-retirement: helping clients balance flexibility with financial security
More Advisor News

Annuity News

  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Global Atlantic launches ForeIncome Flex
  • Athene CEO criticizes offshore reinsurance, risk-taking by competitors
  • DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity News

Health/Employee Benefits News

  • Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
  • Oscar Highlights Tailored New Health Products in Texas for 2027 Open Enrollment
  • States get until July to cut Medicaid coverage over work requirement
  • CRUSH Rule could crush health insurance agents, industry group says
  • Despite rising healthcare costs, enrollment on Nevada insurance exchange is 'pretty steady'
More Health/Employee Benefits News

Life Insurance News

  • Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
  • Military Briefs: November 19-25
  • California’s new solvency rules: What should life insurance advisors watch?
  • Navigating delayed death certificates: A guide for life insurance advisors
  • Jackson Launches Direct-to-Consumer Annuity Offering
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.